良性再発性肝内胆汁うっ滞（BRIC）画像診断機器 - 世界市場シェア・ランキング、全体売上高・需要予測 2024-2030

Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

BRIC画像診断装置市場は、X線画像システム、CTスキャナー、超音波画像システム、MRIシステム、核画像システム、マンモグラフィシステムの6つのセグメントに大別される。良性再発性肝内胆汁うっ滞（BRIC）診断画... もっと見る

出版社	出版年月	電子版価格	言語
QYResearch QYリサーチ	2024年3月1日	US$3,950 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

BRIC画像診断装置市場は、X線画像システム、CTスキャナー、超音波画像システム、MRIシステム、核画像システム、マンモグラフィシステムの6つのセグメントに大別される。
良性再発性肝内胆汁うっ滞（BRIC）診断画像機器の世界市場は、2023年に100万米ドル規模と推定され、2024-2030年の予測期間中に年平均成長率（CAGR）％で2030年までに100万米ドルに再調整されると予測されている。

当社の調査によると、医療機器の世界市場は2023年に6,030億米ドルと推定され、今後6年間のCAGRは5％で成長する。世界の医療支出は世界GDPの10％を占め、高齢化による健康ニーズの増加、慢性疾患や感染症の流行、新興市場の拡大により、近年増加の一途をたどっている。医療機器市場は、ヘルスケア産業において重要な役割を果たしている。この市場を牽引しているのは、世界的な高度医療サービスに対する需要の高まり、医療技術の進歩、高齢者人口の増加、医療費の増加、病気の早期診断・治療に対する意識の高まりなど、いくつかの要因である。

レポートの範囲
本レポートは、良性再発性肝内胆汁うっ滞（BRIC）画像診断機器の世界市場を包括的に紹介することを目的としており、地域別・国別、タイプ別、用途別の良性再発性肝内胆汁うっ滞（BRIC）画像診断機器の分析とともに、総販売量、販売収益、価格、主要企業の市場シェア、ランキングに焦点を当てています。
良性再発性肝内胆汁うっ滞症（BRIC）画像診断装置市場規模、推計、予測は、2023年を基準年として、2019年から2030年までの期間の履歴データと予測データとともに、販売台数（Kユニット）と販売収益（百万ドル）で提供されます。量的および質的分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場での地位を分析し、良性再発性肝内胆汁うっ滞（BRIC）画像診断装置に関する情報に基づいたビジネス上の意思決定を行うのに役立ちます。

市場区分
企業別
アレンジャー
キヤノン
ケアストリームヘルス
CURAヘルスケア
富士フイルム
GEヘルスケア
日立製作所
ホロジック
フィリップスN.V.
ノイソフトコーポレーション
NP JSC アミコ
シーメンス・ヘルティニアス
島津製作所
タイプ別セグメント
X線
MRI
CT
核医学イメージング
用途別セグメント
病院
イメージングセンター
地域別
北米
米国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋
中国
日本
韓国
中国台湾
東南アジア
インド
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦

各章の概要
第1章：レポートのスコープ、世界の総市場規模（バルブ、数量、価格）を紹介します。また、本章では、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を提供します。
第2章良性再発性肝内胆汁うっ滞（BRIC）画像診断機器メーカーの競争環境、価格、売上高、市場シェア、最新の開発計画、合併・買収情報などを詳細に分析します。
第3章：タイプ別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性を網羅し、読者が異なる市場セグメントにおけるブルーオーシャン市場を見つけるのに役立ちます。
第4章：用途別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる下流市場のブルーオーシャン市場を見つけるのを助ける。
第5章良性再発性肝内胆汁うっ滞（BRIC）画像診断装置の地域別売上高、収益。各地域の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場スペース、市場規模を紹介しています。
第6章良性再発性肝内胆汁うっ滞（BRIC）画像診断機器の国別売上高、収益。各国・地域のタイプ別、用途別のシグメイトデータを提供。
第7章：主要企業のプロファイルを提供し、製品の売上高、収益、価格、売上総利益率、製品紹介、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介します。
第8章：産業の上流と下流を含む産業チェーンの分析。
第9章：結論

ページTOPに戻る

1 Market Overview
1.1 Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Product Introduction
1.2 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Size Forecast
1.2.1 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value (2019-2030)
1.2.2 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Volume (2019-2030)
1.2.3 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Price (2019-2030)
1.3 Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Trends & Drivers
1.3.1 Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Industry Trends
1.3.2 Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Drivers & Opportunity
1.3.3 Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Challenges
1.3.4 Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Players Revenue Ranking (2023)
2.2 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Revenue by Company (2019-2024)
2.3 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Players Sales Volume Ranking (2023)
2.4 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Volume by Company Players (2019-2024)
2.5 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Average Price by Company (2019-2024)
2.6 Key Manufacturers Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment
2.9 Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Competitive Analysis
2.9.1 Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 X-Ray
3.1.2 MRI
3.1.3 CT
3.1.4 Nuclear Imaging
3.2 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value by Type
3.2.1 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value, by Type (2019-2030)
3.2.3 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value, by Type (%) (2019-2030)
3.3 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Volume by Type
3.3.1 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Volume, by Type (2019-2030)
3.3.3 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Volume, by Type (%) (2019-2030)
3.4 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Imaging Centers
4.2 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value by Application
4.2.1 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value, by Application (2019-2030)
4.2.3 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value, by Application (%) (2019-2030)
4.3 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Volume by Application
4.3.1 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Volume, by Application (2019-2030)
4.3.3 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Volume, by Application (%) (2019-2030)
4.4 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value by Region
5.1.1 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value by Region (2019-2024)
5.1.3 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value by Region (2025-2030)
5.1.4 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value by Region (%), (2019-2030)
5.2 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Volume by Region
5.2.1 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Volume by Region (2019-2024)
5.2.3 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Volume by Region (2025-2030)
5.2.4 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Volume by Region (%), (2019-2030)
5.3 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value, 2019-2030
5.4.2 North America Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value, 2019-2030
5.5.2 Europe Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value, 2019-2030
5.6.2 Asia Pacific Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value, 2019-2030
5.7.2 South America Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value, 2019-2030
5.8.2 Middle East & Africa Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value
6.2.1 Key Countries/Regions Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value, 2019-2030
6.2.2 Key Countries/Regions Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value, 2019-2030
6.3.2 United States Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value, 2019-2030
6.4.2 Europe Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value, 2019-2030
6.5.2 China Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value, 2019-2030
6.6.2 Japan Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value, 2019-2030
6.7.2 South Korea Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value, 2019-2030
6.8.2 Southeast Asia Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value, 2019-2030
6.9.2 India Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Allengers
7.1.1 Allengers Company Information
7.1.2 Allengers Introduction and Business Overview
7.1.3 Allengers Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Allengers Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Product Offerings
7.1.5 Allengers Recent Development
7.2 Canon
7.2.1 Canon Company Information
7.2.2 Canon Introduction and Business Overview
7.2.3 Canon Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Canon Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Product Offerings
7.2.5 Canon Recent Development
7.3 Carestream Health
7.3.1 Carestream Health Company Information
7.3.2 Carestream Health Introduction and Business Overview
7.3.3 Carestream Health Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Carestream Health Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Product Offerings
7.3.5 Carestream Health Recent Development
7.4 CURA Healthcare
7.4.1 CURA Healthcare Company Information
7.4.2 CURA Healthcare Introduction and Business Overview
7.4.3 CURA Healthcare Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales, Revenue and Gross Margin (2019-2024)
7.4.4 CURA Healthcare Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Product Offerings
7.4.5 CURA Healthcare Recent Development
7.5 FUJIFILM
7.5.1 FUJIFILM Company Information
7.5.2 FUJIFILM Introduction and Business Overview
7.5.3 FUJIFILM Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales, Revenue and Gross Margin (2019-2024)
7.5.4 FUJIFILM Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Product Offerings
7.5.5 FUJIFILM Recent Development
7.6 GE Healthcare
7.6.1 GE Healthcare Company Information
7.6.2 GE Healthcare Introduction and Business Overview
7.6.3 GE Healthcare Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales, Revenue and Gross Margin (2019-2024)
7.6.4 GE Healthcare Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Product Offerings
7.6.5 GE Healthcare Recent Development
7.7 Hitachi Ltd.
7.7.1 Hitachi Ltd. Company Information
7.7.2 Hitachi Ltd. Introduction and Business Overview
7.7.3 Hitachi Ltd. Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Hitachi Ltd. Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Product Offerings
7.7.5 Hitachi Ltd. Recent Development
7.8 Hologic, Inc.
7.8.1 Hologic, Inc. Company Information
7.8.2 Hologic, Inc. Introduction and Business Overview
7.8.3 Hologic, Inc. Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Hologic, Inc. Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Product Offerings
7.8.5 Hologic, Inc. Recent Development
7.9 Koninklijke Philips N.V.
7.9.1 Koninklijke Philips N.V. Company Information
7.9.2 Koninklijke Philips N.V. Introduction and Business Overview
7.9.3 Koninklijke Philips N.V. Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Koninklijke Philips N.V. Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Product Offerings
7.9.5 Koninklijke Philips N.V. Recent Development
7.10 Neusoft Corporation
7.10.1 Neusoft Corporation Company Information
7.10.2 Neusoft Corporation Introduction and Business Overview
7.10.3 Neusoft Corporation Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Neusoft Corporation Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Product Offerings
7.10.5 Neusoft Corporation Recent Development
7.11 NP JSC Amico
7.11.1 NP JSC Amico Company Information
7.11.2 NP JSC Amico Introduction and Business Overview
7.11.3 NP JSC Amico Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales, Revenue and Gross Margin (2019-2024)
7.11.4 NP JSC Amico Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Product Offerings
7.11.5 NP JSC Amico Recent Development
7.12 Siemens Healthineers
7.12.1 Siemens Healthineers Company Information
7.12.2 Siemens Healthineers Introduction and Business Overview
7.12.3 Siemens Healthineers Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Siemens Healthineers Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Product Offerings
7.12.5 Siemens Healthineers Recent Development
7.13 Shimadzu Corporation
7.13.1 Shimadzu Corporation Company Information
7.13.2 Shimadzu Corporation Introduction and Business Overview
7.13.3 Shimadzu Corporation Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Shimadzu Corporation Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Product Offerings
7.13.5 Shimadzu Corporation Recent Development
8 Industry Chain Analysis
8.1 Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Industrial Chain
8.2 Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Sales Model
8.5.2 Sales Channel
8.5.3 Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

ページTOPに戻る

Table of Contents

Summary

BRIC diagnostic imaging equipment market is broadly segmented into six segments—X-ray imaging systems, CT scanners, ultrasound imaging systems, MRI systems, nuclear imaging systems, and mammography systems.
The global market for Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment by region & country, by Type, and by Application.
The Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment.

Market Segmentation
By Company
Allengers
Canon
Carestream Health
CURA Healthcare
FUJIFILM
GE Healthcare
Hitachi Ltd.
Hologic, Inc.
Koninklijke Philips N.V.
Neusoft Corporation
NP JSC Amico
Siemens Healthineers
Shimadzu Corporation
Segment by Type:
X-Ray
MRI
CT
Nuclear Imaging
Segment by Application
Hospitals
Imaging Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

本レポートと同分野の最新刊レポートはありません。

QYResearch 社の最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

QYResearch社はどのような調査会社ですか?

QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

良性再発性肝内胆汁うっ滞（BRIC）画像診断機器 - 世界市場シェア・ランキング、全体売上高・需要予測 2024-2030

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野の最新刊レポート

QYResearch 社の最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

QYResearch社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?